Collaboration to Simplify Document Exchange in Clinical Trials

Published on: 

TransCelerate BioPharma Inc., a non-profit organization with membership comprised of global biopharmaceutical companies, has partnered with Veeva Systems on the Shared Investigator Platform (SIP), a platform that facilitates investigative site collaboration with multiple clinical trial sponsors.   The TransCelerate SIP Initiative aims to provide the industry with a centralized platform that will be interoperable with various clinical solutions, streamline communications between investigators and sponsors, and reduce redundant requests during a trial. It will use the Veeva Vault SiteExchange to improve efficiencies and allow clinical trial investigators, sites, and participating sponsors to have immediate and centralized access to critical documents, eliminating one of the burdens that exists at investigator sites.   For more information on the collaboration, visit